DGAP-Adhoc
Alphaform AG: Alphaform Supervisory Board appoints Thomas Kresser as Chief Financial Officer
Alphaform AG / Key word(s): Change of Personnel
15.09.2014 21:04
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad-hoc disclosure Alphaform AG
Alphaform Supervisory Board appoints Thomas Kresser as Chief Financial
Officer
Feldkirchen, 15 September 2014 - The Supervisory Board of Alphaform AG has
today decided to appoint Mr Thomas Kresser (55) to the company's Management
Board, effective 1 October 2014. He will manage the company as Chief
Financial Officer alongside CEO Dr Hanns-Dieter Aberle. Kresser has more
than 15 years of management experience as General Manager and CFO. He is at
home both in the consumer goods and industrial customer businesses and has
extensive experience in turnaround and restructuring projects and growth
strategies. Most recently, he was Chief Financial Officer at Alstom
Deutschland AG.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
About Alphaform
Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The
company belongs to the European market leaders in the production of complex
components means additive manufacturing, which are often grouped together
under the term '3D printing'. An important mainstay of the segment 3D
Printing an Additive Manufacturing ist the production of series close
prototypes, particularly for the automotive and capital goods industries.
The Medical Devision of Alphaform has al leading position throughout Europe
in manufacturing and processing orthopaedic implants and instruments. The
shares of alphaform are listed in the Prime Standard Segment of the
Frankfurt Stock Exchange (FWB) under the abbreviation ATF.
The core competence of Alphaform lies in its extensive application know how
for processes and materials for additive production of complex prototypes,
tools, individual components and small series made of plastic and metal.
The company's activity is focused on the orthopaedic and medical
technology, automotive, aviation and aerospace industries. The subsidiaries
of Alphaform are located in Germany, Finland, Sweden and the UK.
Contact:
Dr. Hanns-Dieter Aberle, CEO
ALPHAFORM AG
Kapellenstraße 10
85622 Feldkirchen
Tel.: +49 89 905002 35
Fax: +49 89 905002 1035
e-mail: hdaberle@alphaform.de
Internet: www.alphaform.de
Disclaimer
This press release/ad-hoc disclosure is not an offer document and does not
Alphaform Supervisory Board appoints Thomas Kresser as Chief Financial
Officer
Feldkirchen, 15 September 2014 - The Supervisory Board of Alphaform AG has
today decided to appoint Mr Thomas Kresser (55) to the company's Management
Board, effective 1 October 2014. He will manage the company as Chief
Financial Officer alongside CEO Dr Hanns-Dieter Aberle. Kresser has more
than 15 years of management experience as General Manager and CFO. He is at
home both in the consumer goods and industrial customer businesses and has
extensive experience in turnaround and restructuring projects and growth
strategies. Most recently, he was Chief Financial Officer at Alstom
Deutschland AG.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
About Alphaform
Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The
company belongs to the European market leaders in the production of complex
components means additive manufacturing, which are often grouped together
under the term '3D printing'. An important mainstay of the segment 3D
Printing an Additive Manufacturing ist the production of series close
prototypes, particularly for the automotive and capital goods industries.
The Medical Devision of Alphaform has al leading position throughout Europe
in manufacturing and processing orthopaedic implants and instruments. The
shares of alphaform are listed in the Prime Standard Segment of the
Frankfurt Stock Exchange (FWB) under the abbreviation ATF.
The core competence of Alphaform lies in its extensive application know how
for processes and materials for additive production of complex prototypes,
tools, individual components and small series made of plastic and metal.
The company's activity is focused on the orthopaedic and medical
technology, automotive, aviation and aerospace industries. The subsidiaries
of Alphaform are located in Germany, Finland, Sweden and the UK.
Contact:
Dr. Hanns-Dieter Aberle, CEO
ALPHAFORM AG
Kapellenstraße 10
85622 Feldkirchen
Tel.: +49 89 905002 35
Fax: +49 89 905002 1035
e-mail: hdaberle@alphaform.de
Internet: www.alphaform.de
Disclaimer
This press release/ad-hoc disclosure is not an offer document and does not
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte